Solos Endoscopy’s sales increased to just under $98,000 for the period ended March 31, up from about $84,000 for the same period last year.
Management of the company said it expects the increase in sales to continue as global demand for endoscopic instruments increases.
“I am very pleased with the positive turnaround,” said Bob Segersten, president of Solos Endoscopy, in the release. “Solos has been able to reduce its debts and increase its sales in a very short period of time. We believe the company is well positioned for profitability.”
Related Articles on Solos Endoscopy:
Solos Endoscopy to Launch New Endoscopic Instrument Line
Solos Endoscopy Credits Orders for MammoView, Vascular Clamps for Increased Revenues
Solos Endoscopy Completes Capital Restructuring Initiatives
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
